Acorah Software Products - Accounts Production16.1.200falsetrue5 April 20236 April 2022falsetrueNo description of principal activity6 April 20235 April 20245 April 202407597244Mrs Melissa Soiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure075972442023-04-05075972442024-04-05075972442023-04-062024-04-0507597244frs-core:CurrentFinancialInstruments2024-04-0507597244frs-bus:PrivateLimitedCompanyLtd2023-04-062024-04-0507597244frs-bus:FilletedAccounts2023-04-062024-04-0507597244frs-bus:Micro-entities2023-04-062024-04-0507597244frs-bus:AuditExempt-NoAccountantsReport2023-04-062024-04-0507597244frs-bus:Director12023-04-062024-04-05075972442022-04-05075972442023-04-05075972442022-04-062023-04-0507597244frs-core:CurrentFinancialInstruments2023-04-05
Registered number: 07597244
Medex Capital Limited
Unaudited Financial Statements
For The Year Ended 5 April 2024
ACTS Global Ltd
3rd Floor, Norvin House
45-55 Commercial Street
London
E1 6BD
Medex Capital Limited
Balance Sheet
As At 5 April 2024
Balance Sheet
Registered number: 07597244
2024
2023
£
£
Current assets
451,263
521,159
Creditors: Amounts Falling Due Within One Year
(30,018)
(141,055)
NET CURRENT ASSETS
421,245
380,104
TOTAL ASSETS LESS CURRENT LIABILITIES
421,245
380,104
NET ASSETS
421,245
380,104
CAPITAL AND RESERVES
421,245
380,104
Notes
1.General Information
Medex Capital Limited is a private company, limited by shares, incorporated in England & Wales, registered number 07597244. The registered office is Kemp House, 160 City Road, London, EC1V 2NX.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
11
For the year ending 5 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved and authorised for issue by the director on and were signed on 3 January 2025.